Humacyte HUMA
NASDAQ HUMA
$0.44 +0.03 (+7.32%)
At close: Oct 23, 2026 · 4:00 PM EDT

Humacyte (HUMA) Cost of Revenue (2025 - 2026)

Updated

Humacyte (HUMA) recorded Cost of Revenue of $1.23 million in Q2 2026, up 477.9% from $213,000 a year earlier but down 39.6% from the prior quarter.

Analysis

Humacyte (HUMA) Cost of Revenue (2025 - 2026) Analysis & Trends

On a TTM basis, Humacyte's Cost of Revenue came in at $12.61 million as of Jun 30, 2026; for FY2025, it came in at $9.7 million.

  • Quarterly Cost of Revenue has ranged from $147,000 in Q1 2025 to $9.08 million in Q4 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $2.04 million (Q1 2026), $9.08 million (Q4 2025) and $260,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 8.10 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 4.29 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.52 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.58 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.09 Bn
10 Humacyte 122.23 Mn -76.21 Mn -825,000.00 1.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.23 Mn
Mar 31, 2026 2.04 Mn
Dec 31, 2025 9.08 Mn
Sep 30, 2025 260,000.00
Jun 30, 2025 213,000.00
Mar 31, 2025 147,000.00
API Access

Humacyte Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=HUMA&period=max&api_key=YOUR_API_KEY